Cargando…

Hitting the Holy Grail of Hematopoietic Cell Transplantation with Naive T-Cell Depleted Allografts—Graft Engineered Hematopoietic Stem Cell Transplant

Hematopoietic cell transplant is a potentially curative procedure for many benign and malignant conditions. The efficacy of allogeneic transplant relies in part on the cytotoxicity of the conditioning regimen and the graft versus tumor effect mediated by alloreactive donor T cells; the same cells ar...

Descripción completa

Detalles Bibliográficos
Autores principales: El Fakih, Riad, Hashmi, Shahrukh K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618306/
https://www.ncbi.nlm.nih.gov/pubmed/28805723
http://dx.doi.org/10.3390/biomedicines5030048
_version_ 1783267156576698368
author El Fakih, Riad
Hashmi, Shahrukh K.
author_facet El Fakih, Riad
Hashmi, Shahrukh K.
author_sort El Fakih, Riad
collection PubMed
description Hematopoietic cell transplant is a potentially curative procedure for many benign and malignant conditions. The efficacy of allogeneic transplant relies in part on the cytotoxicity of the conditioning regimen and the graft versus tumor effect mediated by alloreactive donor T cells; the same cells are also implicated in the development of graft versus host disease (GVHD). Selective identification and depletion of the T cells implicated in GVHD, while preserving the T cells responsible for graft versus tumor effect has been the focus of many research groups in the recent years. Here we briefly review the physiology of T cells in transplantation, and comment on a recent clinical trial published by Bleakly et al. using a novel way of graft engineered allograft via naïve T cell depletion.
format Online
Article
Text
id pubmed-5618306
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-56183062017-09-29 Hitting the Holy Grail of Hematopoietic Cell Transplantation with Naive T-Cell Depleted Allografts—Graft Engineered Hematopoietic Stem Cell Transplant El Fakih, Riad Hashmi, Shahrukh K. Biomedicines Commentary Hematopoietic cell transplant is a potentially curative procedure for many benign and malignant conditions. The efficacy of allogeneic transplant relies in part on the cytotoxicity of the conditioning regimen and the graft versus tumor effect mediated by alloreactive donor T cells; the same cells are also implicated in the development of graft versus host disease (GVHD). Selective identification and depletion of the T cells implicated in GVHD, while preserving the T cells responsible for graft versus tumor effect has been the focus of many research groups in the recent years. Here we briefly review the physiology of T cells in transplantation, and comment on a recent clinical trial published by Bleakly et al. using a novel way of graft engineered allograft via naïve T cell depletion. MDPI 2017-08-14 /pmc/articles/PMC5618306/ /pubmed/28805723 http://dx.doi.org/10.3390/biomedicines5030048 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Commentary
El Fakih, Riad
Hashmi, Shahrukh K.
Hitting the Holy Grail of Hematopoietic Cell Transplantation with Naive T-Cell Depleted Allografts—Graft Engineered Hematopoietic Stem Cell Transplant
title Hitting the Holy Grail of Hematopoietic Cell Transplantation with Naive T-Cell Depleted Allografts—Graft Engineered Hematopoietic Stem Cell Transplant
title_full Hitting the Holy Grail of Hematopoietic Cell Transplantation with Naive T-Cell Depleted Allografts—Graft Engineered Hematopoietic Stem Cell Transplant
title_fullStr Hitting the Holy Grail of Hematopoietic Cell Transplantation with Naive T-Cell Depleted Allografts—Graft Engineered Hematopoietic Stem Cell Transplant
title_full_unstemmed Hitting the Holy Grail of Hematopoietic Cell Transplantation with Naive T-Cell Depleted Allografts—Graft Engineered Hematopoietic Stem Cell Transplant
title_short Hitting the Holy Grail of Hematopoietic Cell Transplantation with Naive T-Cell Depleted Allografts—Graft Engineered Hematopoietic Stem Cell Transplant
title_sort hitting the holy grail of hematopoietic cell transplantation with naive t-cell depleted allografts—graft engineered hematopoietic stem cell transplant
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618306/
https://www.ncbi.nlm.nih.gov/pubmed/28805723
http://dx.doi.org/10.3390/biomedicines5030048
work_keys_str_mv AT elfakihriad hittingtheholygrailofhematopoieticcelltransplantationwithnaivetcelldepletedallograftsgraftengineeredhematopoieticstemcelltransplant
AT hashmishahrukhk hittingtheholygrailofhematopoieticcelltransplantationwithnaivetcelldepletedallograftsgraftengineeredhematopoieticstemcelltransplant